Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity

PURPOSE: To study the effects of a neutralizing antibody to vascular endothelial growth factor (VEGF), given as an intravitreous injection, on intravitreous neovascularization (IVNV) and ongoing vascular development of avascular retina in a rat model relevant to human retinopathy of prematurity. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Geisen, P., Peterson, L. J., Martiniuk, D., Uppal, Ahbineet, Saito, Y., Hartnett, M. Elizabeth
Formato: Texto
Lenguaje:English
Publicado: Molecular Vision 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2258217/
https://www.ncbi.nlm.nih.gov/pubmed/18334951

Ejemplares similares

Ejemplares similares